Results

Total Results: 6,078 records

Showing results for "disorders".

  1. psnet.ahrq.gov/web-mm/managing-complexity-diagnosis-life-threatening-complications-after-gastric-bypass-surgery
    September 25, 2019 - Neuropsychiatric and neuropsychological aspects of alcohol-related cognitive disorders: an in-depth review
  2. meps.ahrq.gov/data_files/publications/st541/stat541.shtml
    March 01, 2022 - recommended as the first-line treatment for most types of pain due to serious risks of opioid use disorders
  3. psnet.ahrq.gov/web-mm/delayed-diagnosis-setting-virtual-care-remembering-physical-examination
    April 29, 2020 - resulting in loss of vision, paralysis, sensory loss, ataxia, adverse brainstem signs, psychiatric disorders
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/thMRXgCVQmNUsYo6dmXEc3
    May 01, 2004 - Photorefractor for detection of treatable eye disorders in preverbal children.
  5. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/model/evidence-now-sustainable-funding-resource.pdf
    February 01, 2023 - chronic disease management and to design and implement systems to screen for alcohol and substance use disorders
  6. psnet.ahrq.gov/web-mm/fatal-twist-pseudohyperkalemia
    February 10, 2021 - Potassium disorders: hypokalemia and hyperkalemia.
  7. hcup-us.ahrq.gov/reports/statbriefs/sb151.jsp
    March 01, 2013 - changes in rates for long-term diabetes complications (i.e., renal, visual, neurological, and circulatory disorders
  8. hcup-us.ahrq.gov/reports/statbriefs/sb116.pdf
    June 14, 2011 - 3,977,790 4.3 Headache; including migraine 4 223,327 3.6 7 2,465,250 2.7 Spondylosis; intervertebral disc disorders
  9. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-215-fullreport.pdf
    August 01, 2017 - Sickle Cell Disease Prevalence and Incidence SCD is one of the most common genetic disorders in the
  10. www.ahrq.gov/sites/default/files/2024-01/lo-report.pdf
    January 01, 2024 - Drug-induced liver disorders: implications for drug development and regulation. … Liver disorders in patients receiving chlorpromazine or isoniazid.
  11. effectivehealthcare.ahrq.gov/products/women-hiv/research-protocol
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
    August 01, 2012 - Investigator Other Experts Conclusion from SCEPC Validity of CER conclusion(s) mg/kg/week) for disorders … incidence from non-CF patients receiving modest doses of rhGH (0.2 mg/kg/week to 0.6 mg/kg/week) for disorders … (Pfizer Database) 18 KIGS database was established in 1987 to monitor children with growth disorders … incidence from non-CF patients receiving modest doses of rhGH (0.2 mg/kg/week to 0.6 mg/kg/week) for disorders
  13. hcup-us.ahrq.gov/db/nation/nis/NISIntroduction2010.pdf
    November 01, 2015 - , (1) Comorbidity is present CM_LYTES 2002-2010 AHRQ comorbidity measure: Fluid and electrolyte disorders … (1) Comorbidity is present CM_PERIVASC 2002-2010 AHRQ comorbidity measure: Peripheral vascular disorders … ) Comorbidity is present CM_PULMCIRC 2002-2010 AHRQ comorbidity measure: Pulmonary circulation disorders … parasitic disease, (2) Neoplasms, (3) Endocrine, nutritional, and metabolic diseases and immunity disorders … , (4) Diseases of blood and blood-forming organs, (5) Mental disorders, (6) Diseases of the nervous
  14. hcup-us.ahrq.gov/db/nation/nis/NIS_2009_INTRODUCTION.pdf
    January 01, 2009 - , (1) Comorbidity is present CM_LYTES 2002-2009 AHRQ comorbidity measure: Fluid and electrolyte disorders … (1) Comorbidity is present CM_PERIVASC 2002-2009 AHRQ comorbidity measure: Peripheral vascular disorders … ) Comorbidity is present CM_PULMCIRC 2002-2009 AHRQ comorbidity measure: Pulmonary circulation disorders … parasitic disease, (2) Neoplasms, (3) Endocrine, nutritional, and metabolic diseases and immunity disorders … , (4) Diseases of blood and blood-forming organs, (5) Mental disorders, (6) Diseases of the nervous
  15. hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2011.pdf
    January 01, 2011 - , (1) Comorbidity is present CM_LYTES 2002-2011 AHRQ comorbidity measure: Fluid and electrolyte disorders … (1) Comorbidity is present CM_PERIVASC 2002-2011 AHRQ comorbidity measure: Peripheral vascular disorders … ) Comorbidity is present CM_PULMCIRC 2002-2011 AHRQ comorbidity measure: Pulmonary circulation disorders … parasitic disease, (2) Neoplasms, (3) Endocrine, nutritional, and metabolic diseases and immunity disorders … , (4) Diseases of blood and blood-forming organs, (5) Mental disorders, (6) Diseases of the nervous
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/smoking-pregnancy-infants_research-protocol.pdf
    March 11, 2013 - Smoking patterns and outcomes in a population of pregnant women with other substance use disorders. … [Conduct disorders in seven-year-old children—results of ELSPAC study. 3. Postnatal development].
  17. cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdf
    January 01, 2020 - CDS Connect Maintenance and Update Final Report Year 4 2020 CDS Connect CDS Connect Maintenance and Update Final Report (Year 4 of CDS Connect) Final Report (Year 4 of CDS Connect) CDS Connect Maintenance and Update Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 …
  18. digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year4-final-report-2020.pdf
    January 01, 2020 - CDS Connect Maintenance and Update Final Report Year 4 2020 CDS Connect CDS Connect Maintenance and Update Final Report (Year 4 of CDS Connect) Final Report (Year 4 of CDS Connect) CDS Connect Maintenance and Update Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 …
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
    March 28, 2019 - CER 215 Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults Draft review available for public comment from May 13, 201…
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
    March 21, 2013 - Peer reviewer #7 (TEP) Executive Summary ES-1 l. 40 anovulatory doesn’t mean ovulatory disorders … Investigators did not systematically evaluate for the presence of disorders of hemostasis.